Correlation Between Champions Oncology and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Champions Oncology and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Mineralys Therapeutics,.
Diversification Opportunities for Champions Oncology and Mineralys Therapeutics,
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Champions and Mineralys is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Champions Oncology i.e., Champions Oncology and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Champions Oncology and Mineralys Therapeutics,
Given the investment horizon of 90 days Champions Oncology is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Champions Oncology is 1.23 times less risky than Mineralys Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,170 in Mineralys Therapeutics, Common on August 25, 2024 and sell it today you would earn a total of 79.00 from holding Mineralys Therapeutics, Common or generate 6.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Champions Oncology |
| Mineralys Therapeutics, |
Champions Oncology and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Mineralys Therapeutics,
The main advantage of trading using opposite Champions Oncology and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |